Board of Directors

Nandini Piramal is the Non-Executive Director at Piramal Enterprises and Chairperson at Piramal Pharma Ltd. She is responsible for setting strategy and driving results at Piramal Pharma. Piramal Pharma offers a portfolio of differentiated products and services through its 17 global development and manufacturing facilities and a global distribution network in over 100 countries.

Additionally, she heads the Human Resources, Finance, Risk, Information Technology and Quality functions at Piramal Pharma.

Ms. Piramal is also an advisor to Piramal Foundation which has impacted the lives of over 113 mm Indians in its lifetime in areas ranging from gender, public health to education and purified water.

She is a visionary business leader driven by her commitment to bettering society. Her efforts in the business and social world led to her being recognized amongst ‘India’s Most Powerful Women’ by Business Today in 2020, 2022 and 2023 for her outstanding contribution in business and social growth. She was also awarded as a `Young Global Leader’ in 2014 by the World Economic Forum.

Ms. Piramal holds a BA (Hons.) in Politics, Philosophy, and Economics from Oxford University. She also has an MBA from Stanford Graduate School of Business.

Peter DeYoung is the CEO of Piramal Global Pharma, Piramal Pharma Limited, and a member of the Piramal Pharma Limited Board. Piramal Global Pharma is comprised of Piramal Pharma Solutions and Piramal Critical Care business units. In his current role, Peter is responsible for steering strategy and driving profitable growth of these businesses.

Prior to this, he has spearheaded several leadership mandates at the Piramal Group, including CEO, Piramal Critical Care and President, Life Sciences.

Previously, Mr. DeYoung worked in various investing and consulting roles in healthcare in the USA, Europe and India. He joined McKinsey & Company in New York after graduating from Princeton, where he worked on a number of projects for pharmaceutical and medical device companies. He was then seconded by McKinsey to the World Economic Forum in Geneva, Switzerland as part of the Global Health Initiative. Mr. DeYoung returned to McKinsey in New York and later in Mumbai, where he focused on the pharmaceutical and healthcare practice. Later, he joined the Blackstone Group’s Private Equity Division in Mumbai where he was part of the deal team for several significant transactions, across a wide spectrum of industry sectors in India.

Mr. DeYoung holds a Master’s Degree in Business Administration from Stanford University (Arjay Miller Scholar), California, USA and a Bachelor’s of Science Degree in Engineering from Princeton University, New Jersey, USA (summa cum laude).

With 28 years of overall experience in the field of Finance, Mr. Vivek Valsaraj has been associated with the Piramal Group for over 23 years. As the Chief Financial Officer of Piramal Pharma Ltd, he currently oversees the Finance, Investor Relations and Shared Services Functions. Mr. Valsaraj is also serving on the board of the joint venture company of Piramal Pharma, Abbvie Therapeutics India Private Limited (formerly known as Allergan India Private Limited) and several overseas subsidiaries.

Within the group, he has been associated with various roles in Corporate and the erstwhile Domestic Formulations business. His expertise spans across Corporate Finance, Business Strategy, Mergers and Acquisitions, Corporate Structuring, Fund raising, Corporate Governance Enterprise Risk Management, and Taxation. Over the last several years, he has been closely associated with the Pharma business and has been a part of several key M&A transactions and capital raising. He has also played a key role in streamlining and finessing systems, processes, and internal controls.

Prior to joining Piramal, he was associated with companies like Wockhardt Ltd and Bharat Bijlee Ltd. He holds a Bachelor’s degree in Commerce and is an Associate member of the Institute of Cost Accountants of India.

Mr. S. Ramadorai was in public service from February 2011 to October 2016. During his tenure as the Chairman of the National Skill Development Agency (NSDA) and the National Skill Development Corporation (NSDC) his approach was to standardize the skilling effort, ensure quality and commonality of outcomes by leveraging technology and create an inclusive environment to co-operate, collaborate & co-exist. He strongly believed that empowering the youth with the right skills can define the future of the country. Currently, he is the Chairperson of Mission ‘Karmayogi Bharat’, the National Programme for Civil Services Capacity Building (NPCSCB) that aims to transform Indian bureaucracy and prepare civil servants for the future, through comprehensive reform of the capacity building apparatus at individual, institutional and process levels.

Mr. Ramadorai is also the Chairman of the Advisory Board at Tata STRIVE, which is the Tata Group’s CSR skill development initiative that aims to address the pressing national need of skilling youth for employment, entrepreneurship and community enterprise. Currently, he serves as an Independent Director on the Boards of Piramal Pharma Limited and DSP Asset Managers Pvt. Ltd. In March 2016, he retired as the Chairman of the Bombay Stock Exchange (BSE Ltd.) after having served on their board for a period of 6 years.

Mr. Ramadorai took over as the CEO of Tata Consultancy Services (TCS) in 1996 when the company’s revenues were at $ 155 million and since then led the company through some of its most exciting phases, including its going public in 2004. In October 2009, he retired as the CEO, leaving a $ 6 billion global IT services company to his successor. He was then appointed as the Vice Chairman and retired in October 2014, after an association of over 4 decades with the company.

Given his keen passion to work for the social sector and community initiatives, he also serves as the Chairman on the Council of Management at the National Institute of Advanced Studies (NIAS) and was the Chairperson of the Governing Board at the Tata Institute of Social Sciences (TISS) for over 10 years starting October 2011. He is the Chairperson of Public Health Foundation of India and the President of the Society for Rehabilitation of Crippled Children (SRCC) – which has recently built a super specialty children’s hospital in Mumbai. In February 2020, Mr. Ramadorai was also appointed as the Chairperson of the Kalakshetra Foundation’s Governing Board by the Union Ministry of Culture.

In recognition of his commitment and dedication to the IT industry he was awarded the Padma Bhushan (India's third highest civilian honour) in January 2006. In April 2009, he was awarded the CBE (Commander of the Order of the British Empire) by Her Majesty Queen Elizabeth II for his contribution to the Indo-British economic relations. In 2016, he was also awarded The Economic Times - Lifetime Achievement Award for his glorious contribution to Tata Consultancy Services.

His academic credentials include a Bachelor’s degree in Physics from Delhi University (India), a Bachelor of Engineering degree in Electronics and Telecommunications from the Indian Institute of Science, Bengaluru (India) and a Master’s degree in Computer Science from the University of California – UCLA (USA). In 1993, Ramadorai attended the Sloan School of Management’s highly acclaimed Senior Executive Development Program.

Ramadorai is a well-recognized global leader and technocrat who has participated in the Indian IT journey from a mere idea in 1960’s to a mature industry today. Ramadorai captured this exciting journey in a wonderfully personalized book titled 'The TCS Story...and beyond' which was published in 2011 and remained on top of the charts for several months.

Among his many interests, Ramadorai is also passionate about photography and Indian classical music.

Mr. Peter Stevenson is a leader in the pharmaceutical industry with extensive manufacturing and commercial experience. He was a member of Pfizer’s Global Manufacturing Leadership Team with responsibilities for global procurement, global external supply and a portfolio of Pfizer internal manufacturing sites in North America, Europe and Asia.

Later, he served as General Manager of Pfizer’s contract manufacturing business and as Value Stream Leader for the Injectables and Hospital Products Value Stream and retired from the role of Vice President, General Manager, Pfizer Centre One in 2019.

Mr. Stevenson also served on the Board of Uniting to Combat Neglected Tropical Diseases.

Earlier in his career, Mr. Stevenson held positions at Rhone Poulenc and Celanese including a 3-year expatriate assignment in France.

He holds a Bachelor’s degree in Arts from Gettysburg College, Pennsylvania.

Mr. Jairaj Purandare has over four decades of experience in accounting, tax, and business advisory. He is an authority on tax and regulation. He has published papers on subjects like inbound/outbound investment structuring, international tax, transfer pricing, M&As and Indian Budget and Economy. Mr. Purandare has advised clients across various industries such as Financial Services, Infrastructure, Power, Telecom, Media, Pharma and Auto sectors that include Citibank, GE, HSBC, Hutchison, Pepsico, Standard Chartered Bank, News Corp /STAR TV and Tata Group.

Mr. Purandare is the Founder Chairman of JMP Advisors Pvt Ltd, a leading advisory, accounting, tax and regulatory services firm in India. His previous associations has been with firms in various roles such as Regional Managing Partner, Chairman - Tax and Country Leader, Markets & Industries of PricewaterhouseCoopers (PwC) India, Chairman of Ernst & Young India (EY) and the Country Head of the Tax & Business Advisory practice of Andersen India.

Mr. Purandare is an Independent Director on the Boards of four large, public limited companies. He is a frequent speaker at Indian and international seminars and industry forums.

Mr. Purandare is a Fellow of the Institute of Chartered Accountants of India, a steering committee member for the ITSG International Network, and a member of the City of London Advisory Council for India. He is a former member of the National Council of Confederation of Indian Industry (CII) and former Chairman of the Taxation Committee of CII. He has been a member of the Central Direct Taxes Advisory Committee, chaired by the Finance Minister. Mr. Purandare is a YPO Gold member and the Regional Networks Chair and Finance Chair of YPO.

Mr. Purandare has completed the YPO Presidents Program from Harvard Business School and holds a Bachelor of Science (Hons) degree from the University of Bombay.

Ms. Vibha Paul Rishi is a Non-Executive Independent Director, Piramal Pharma Limited.

Ms. Rishi is a marketing professional, specializing in Indian and international markets. She has worked at senior positions globally in branding, strategy, innovation and human capital. She started her career with the Tata Administrative Services and was part of Titan Watches’ founding team. Ms. Rishi had a long association with PepsiCo spanning close to two decades in marketing and innovation roles for India, USA and the UK. She was also the Executive Director (Brand and Human Capital) at Max India Ltd. and the Director (Marketing and Customer Strategy) at the Future Group with stints across the globe, coupled with an abiding passion for people.

Ms. Rishi currently serves on the board of several reputed companies including Tata Chemicals Limited, ICICI Bank Limited, ICICI Prudential Life Insurance Company Limited, Asian Paints Limited and others. She is also on the Board of Pratham, an NGO that works to provide education to underprivileged children in India.

Ms. Rishi holds a BA Degree in Economics from Lady Sri Ram College, University of Delhi and an MBA with specialization in marketing from the Faculty of Management Studies, New Delhi.

Mr. Sridhar Gorthi is a founding partner and member of the Management Committee at Trilegal. He is an authority in corporate law, M&A, and private equity, spanning across sectors including manufacturing, pharmaceuticals, insurance, banking and financial services, technology, telecom and media.

His domain knowledge has earned him the recognition of Asian Law Firm Leader of the Year - Asia Legal Awards 2023, 'Leading Individual' - Corporate M&A, Legal 500 Asia Pacific for 2024 and a distinguished practitioner for Corporate M&A and private Equity by the Asia Law Profiles (2023). His name also lists as a 'Highly Regarded’ lawyer – M&A by IFLR1000 (2019-2023). He is among India Business Law Journal’s A-list 2023 of top 100 lawyers in India, and among Chambers and Partners’ Asia Pacific’s leading lawyers in India for Banking and Finance (2014-2024).

Mr. Gorthi is a graduate from National Law School, Bengaluru, and is a member of the Bar Council of Maharashtra and Goa.

Mr. Neeraj Bharadwaj is the Managing Director of Carlyle India Advisors Private Limited, focused on growth capital and buyout opportunities across sectors in India. Prior to joining Carlyle in 2012, Mr. Bharadwaj was a Managing Director with Accel Partners’ growth investing operation in India.

Preceding that he was with Apax Partners for nearly 10 years - he was a Partner in the U.S. and subsequently Managing Director/Country Head for Apax in India, where he led the India operations. Investments he has been involved with include Apollo Hospitals (BSE: AHEL), Jamdat (NASDAQ: JMDT), Wider than (NASDAQ: WTHN) and others. Previously, Mr. Bharadwaj was an engagement manager at McKinsey & Co. Mr. Bharadwaj was selected as Board Member of the Indian School of Business (ISB), a Young Global Leader of the World Economic Forum (WEF), Board Member of Olympic Gold Quest (OGQ), Member of the Harvard Business School South Asia Advisory Board, Member of the Wharton Executive Education Board, Member of the Young Presidents’ Organization and previously chaired the FICCI Committee on Private Equity & Venture Capital.

Mr. Bharadwaj serves on the boards of Hexaware Technologies Limited, Indegene Limited, Nxtra Data Limited, Sequent Scientific Limited, CorroHealth Infotech Pvt. Limited and others. Previously, he served on the boards of Delhivery Limited, Global Health Limited, Metropolis Healthcare Limited, and others.

Mr. Bharadwaj holds an MBA with distinction from Harvard Business School, and graduated summa cum laude with a BS in economics from the Wharton School of the University of Pennsylvania.